1	Evaluation	Evaluation	B-NP	NN	O	12	NMOD	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	electrical	electrical	B-NP	JJ	O	4	NMOD	0
4	stimulation	stimulation	I-NP	NN	O	2	PMOD	0
5	for	for	B-PP	IN	O	4	NMOD	0
6	ischemic	ischemic	B-NP	JJ	O	8	NMOD	0
7	wound	wound	I-NP	NN	O	8	NMOD	0
8	therapy	therapy	I-NP	NN	O	5	PMOD	0
9	:	:	O	:	O	1	P	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	feasibility	feasibility	I-NP	NN	O	12	NMOD	0
12	study	study	I-NP	NN	O	0	ROOT	0
13	using	use	B-VP	VBG	O	12	NMOD	0
14	the	the	B-NP	DT	O	17	NMOD	0
15	lapine	lapine	I-NP	NN	O	17	NMOD	0
16	wound	wound	I-NP	NN	O	17	NMOD	0
17	model	model	I-NP	NN	O	13	OBJ	0
18	.	.	O	.	O	12	P	0

1	Chronic	Chronic	B-NP	JJ	O	2	NMOD	0
2	wounds	wound	I-NP	NNS	O	3	SUB	0
3	are	be	B-VP	VBP	O	0	ROOT	0
4	a	a	B-NP	DT	O	7	NMOD	0
5	major	major	I-NP	JJ	O	7	NMOD	0
6	secondary	secondary	I-NP	JJ	O	7	NMOD	0
7	complication	complication	I-NP	NN	O	3	PRD	0
8	for	for	B-PP	IN	O	7	NMOD	0
9	many	many	B-NP	JJ	O	10	NMOD	0
10	people	people	I-NP	NNS	O	8	PMOD	0
11	with	with	B-PP	IN	O	10	NMOD	0
12	impaired	impaired	B-NP	JJ	O	13	NMOD	0
13	mobility	mobility	I-NP	NN	O	11	PMOD	0
14	.	.	O	.	O	3	P	0

1	Electrical	Electrical	B-NP	JJ	O	2	NMOD	0
2	stimulation	stimulation	I-NP	NN	O	6	SUB	0
3	(	(	O	(	O	5	DEP	0
4	ES	ES	B-NP	NN	O	5	DEP	0
5	)	)	O	)	O	2	NMOD	0
6	has	have	B-VP	VBZ	O	18	VMOD	0
7	been	be	I-VP	VBN	O	6	VC	0
8	recommended	recommend	I-VP	VBN	O	7	VC	0
9	as	as	B-PP	IN	O	8	VMOD	0
10	a	a	B-NP	DT	O	12	NMOD	0
11	adjunctive	adjunctive	I-NP	JJ	O	12	NMOD	0
12	therapy	therapy	I-NP	NN	O	9	PMOD	0
13	,	,	O	,	O	18	P	0
14	however	however	B-NP	RB	O	18	VMOD	0
15	optimal	optimal	I-NP	JJ	O	17	NMOD	0
16	treatment	treatment	I-NP	NN	O	17	NMOD	0
17	paradigms	paradigm	I-NP	NNS	O	18	SUB	0
18	have	have	B-VP	VBP	O	0	ROOT	0
19	not	not	I-VP	RB	O	18	VMOD	0
20	been	be	I-VP	VBN	O	18	VC	0
21	established	establish	I-VP	VBN	O	20	VC	0
22	.	.	O	.	O	18	P	0

1	Our	Our	B-NP	PRP$	O	2	NMOD	0
2	group	group	I-NP	NN	O	3	SUB	0
3	seeks	seek	B-VP	VBZ	O	0	ROOT	0
4	to	to	I-VP	TO	O	5	VMOD	0
5	determine	determine	I-VP	VB	O	3	VMOD	0
6	the	the	B-NP	DT	O	8	NMOD	0
7	basic	basic	I-NP	JJ	O	8	NMOD	0
8	mechanisms	mechanism	I-NP	NNS	O	5	OBJ	0
9	underlying	underlie	B-VP	VBG	O	8	NMOD	0
10	ES	ES	B-NP	NN	O	12	NMOD	0
11	wound	wound	I-NP	NN	O	12	NMOD	0
12	therapy	therapy	I-NP	NN	O	15	NMOD	0
13	,	,	O	,	O	15	P	0
14	an	an	B-NP	DT	O	15	NMOD	0
15	area	area	I-NP	NN	O	9	OBJ	0
16	where	where	B-ADVP	WRB	O	9	VMOD	0
17	understanding	understand	B-VP	VBG	O	18	SUB	0
18	is	be	B-VP	VBZ	O	16	SBAR	0
19	currently	currently	I-VP	RB	O	18	VMOD	0
20	limited	limit	I-VP	VBN	O	18	VC	0
21	.	.	O	.	O	3	P	0

1	A	A	B-NP	DT	O	3	NMOD	0
2	feasibility	feasibility	I-NP	NN	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	0
5	carried	carry	I-VP	VBN	O	4	VC	0
6	out	out	B-PRT	RP	O	5	VMOD	0
7	to	to	B-VP	TO	O	8	VMOD	0
8	develop	develop	I-VP	VB	O	4	VMOD	0
9	the	the	B-NP	DT	O	13	NMOD	0
10	Ahn/Mustoe	Ahn/Mustoe	I-NP	NN	O	13	NMOD	0
11	lapine	lapine	I-NP	NN	O	13	NMOD	0
12	wound	wound	I-NP	NN	O	13	NMOD	0
13	model	model	I-NP	NN	O	8	OBJ	0
14	for	for	B-PP	IN	O	13	NMOD	0
15	systematic	systematic	B-NP	JJ	O	16	NMOD	0
16	investigation	investigation	I-NP	NN	O	14	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	effects	effect	I-NP	NNS	O	17	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	electrical	electrical	B-NP	JJ	O	22	NMOD	0
22	stimulation	stimulation	I-NP	NN	O	20	PMOD	0
23	on	on	B-PP	IN	O	19	NMOD	0
24	ischemic	ischemic	B-NP	JJ	O	26	NMOD	0
25	wound	wound	I-NP	NN	O	26	NMOD	0
26	therapy	therapy	I-NP	NN	O	23	PMOD	0
27	.	.	O	.	O	4	P	0

1	A	A	B-NP	DT	O	4	NMOD	0
2	standardized	standardized	I-NP	JJ	O	4	NMOD	0
3	surgical	surgical	I-NP	JJ	O	4	NMOD	0
4	procedure	procedure	I-NP	NN	O	5	SUB	0
5	incorporated	incorporate	B-VP	VBD	O	0	ROOT	0
6	a	a	B-NP	DT	O	9	NMOD	0
7	hybrid	hybrid	I-NP	NN	O	9	NMOD	0
8	stimulation	stimulation	I-NP	NN	O	9	NMOD	0
9	system	system	I-NP	NN	O	5	OBJ	0
10	comprising	comprise	B-VP	VBG	O	9	NMOD	0
11	an	an	B-NP	DT	O	13	NMOD	0
12	implantable	implantable	I-NP	JJ	O	13	NMOD	0
13	mini-stimulator	mini-stimulator	I-NP	NN	O	16	NMOD	0
14	and	and	I-NP	CC	O	16	NMOD	0
15	surface	surface	I-NP	NN	O	16	NMOD	0
16	electrodes	electrode	I-NP	NNS	O	10	OBJ	0
17	,	,	O	,	O	5	P	0
18	with	with	B-PP	IN	O	5	VMOD	0
19	creation	creation	B-NP	NN	O	18	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	repeatable	repeatable	B-NP	JJ	O	23	NMOD	0
22	ischemic	ischemic	I-NP	JJ	O	23	NMOD	0
23	wounds	wound	I-NP	NNS	O	20	PMOD	0
24	.	.	O	.	O	5	P	0

1	Twenty	Twenty	B-NP	CD	O	7	NMOD	0
2	mature	mature	I-NP	JJ	O	7	NMOD	0
3	male	male	I-NP	JJ	O	7	NMOD	0
4	New	New	I-NP	NNP	O	7	NMOD	0
5	Zealand	Zealand	I-NP	NNP	O	7	NMOD	0
6	white	white	I-NP	JJ	O	7	NMOD	0
7	rabbits	rabbit	I-NP	NNS	O	13	SUB	0
8	(	(	O	(	O	12	DEP	0
9	3	3	B-NP	CD	O	11	NMOD	0
10	kg	kg	I-NP	NN	O	11	NMOD	0
11	weight	weight	I-NP	NN	O	12	DEP	0
12	)	)	O	)	O	7	NMOD	0
13	were	be	B-VP	VBD	O	0	ROOT	0
14	employed	employ	I-VP	VBN	O	13	VC	0
15	to	to	I-VP	TO	O	16	VMOD	0
16	evaluate	evaluate	I-VP	VB	O	13	VMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	effects	effect	I-NP	NNS	O	16	OBJ	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	two	two	B-NP	CD	O	24	NMOD	0
21	empirically	empirically	I-NP	RB	O	22	AMOD	0
22	selected	select	I-NP	VBN	O	24	NMOD	0
23	stimulation	stimulation	I-NP	NN	O	24	NMOD	0
24	paradigms	paradigm	I-NP	NNS	O	19	PMOD	0
25	applied	apply	B-VP	VBD	O	16	VMOD	0
26	continuously	continuously	B-ADVP	RB	O	25	VMOD	0
27	for	for	B-PP	IN	O	25	VMOD	0
28	7-21	7-21	B-NP	CD	O	29	NMOD	0
29	days	day	I-NP	NNS	O	27	PMOD	0
30	,	,	O	,	O	16	P	0
31	using	use	B-VP	VBG	O	16	VMOD	0
32	each	each	B-NP	DT	O	33	NMOD	0
33	animal	animal	I-NP	NN	O	31	OBJ	0
34	as	as	B-PP	IN	O	31	VMOD	0
35	its	its	B-NP	PRP$	O	37	NMOD	0
36	own	own	I-NP	JJ	O	37	NMOD	0
37	control	control	I-NP	NN	O	34	PMOD	0
38	.	.	O	.	O	13	P	0

1	Outcomes	Outcome	B-NP	NNS	O	2	NMOD	0
2	measures	measure	I-NP	NNS	O	3	SUB	0
3	included	include	B-VP	VBD	O	0	ROOT	0
4	transcutaneous	transcutaneous	B-NP	JJ	O	7	NMOD	0
5	blood	blood	I-NP	NN	O	7	NMOD	0
6	gas	gas	I-NP	NN	O	7	NMOD	0
7	levels	level	I-NP	NNS	O	15	NMOD	0
8	,	,	O	,	O	15	P	0
9	histology	histology	B-NP	NN	O	15	NMOD	0
10	,	,	O	,	O	15	P	0
11	total	total	B-NP	JJ	O	13	NMOD	0
12	RNA	RNA	I-NP	NN	O	13	NMOD	0
13	content	content	I-NP	NN	O	15	NMOD	0
14	and	and	O	CC	O	15	NMOD	0
15	analysis	analysis	B-NP	NN	O	46	NMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	alpha2	alpha2	B-NP	NN	B-protein	21	NMOD	0
18	(	(	O	(	I-protein	21	NMOD	0
19	I	I	B-NP	NN	I-protein	21	NMOD	0
20	)	)	O	)	I-protein	21	NMOD	0
21	collagen	collagen	B-NP	NN	I-protein	37	NMOD	0
22	(	(	O	(	O	24	DEP	0
23	COL-I	COL-I	B-NP	NN	B-protein	24	DEP	0
24	)	)	O	)	O	21	NMOD	0
25	,	,	O	,	O	37	P	0
26	type	type	B-NP	NN	B-protein	28	NMOD	0
27	IV	IV	I-NP	CD	I-protein	28	NMOD	0
28	collagen	collagen	I-NP	NN	I-protein	37	NMOD	0
29	(	(	O	(	O	31	DEP	0
30	COL-IV	COL-IV	B-NP	NN	B-protein	31	DEP	0
31	)	)	O	)	O	28	NMOD	0
32	,	,	O	,	O	37	P	0
33	alpha1	alpha1	B-NP	NN	B-protein	37	NMOD	0
34	(	(	O	(	I-protein	37	NMOD	0
35	V	V	B-NP	NN	I-protein	37	NMOD	0
36	)	)	O	)	I-protein	37	NMOD	0
37	collagen	collagen	B-NP	NN	I-protein	16	PMOD	0
38	(	(	O	(	O	40	DEP	0
39	COL-V	COL-V	B-NP	NN	B-protein	40	DEP	0
40	)	)	O	)	O	37	NMOD	0
41	,	,	O	,	O	15	P	0
42	and	and	O	CC	O	46	NMOD	0
43	vascular	vascular	B-NP	JJ	B-protein	46	NMOD	0
44	endothelial	endothelial	I-NP	JJ	I-protein	46	NMOD	0
45	growth	growth	I-NP	NN	I-protein	46	NMOD	0
46	factor	factor	I-NP	NN	I-protein	50	NMOD	0
47	(	(	O	(	O	49	DEP	0
48	VEGF	VEGF	B-NP	NN	B-protein	49	DEP	0
49	)	)	O	)	O	46	NMOD	0
50	expression	expression	B-NP	NN	O	3	OBJ	9	expression
51	using	use	B-VP	VBG	O	50	NMOD	0
52	real-time	real-time	B-NP	JJ	O	53	AMOD	0
53	quantitative	quantitative	I-NP	JJ	O	54	NMOD	0
54	PCR	PCR	I-NP	NN	O	51	OBJ	0
55	.	.	O	.	O	3	P	0

1	All	All	B-NP	DT	O	2	NMOD	0
2	markers	marker	I-NP	NNS	O	6	SUB	0
3	for	for	B-PP	IN	O	2	NMOD	0
4	stimulated	stimulate	B-NP	VBN	O	5	NMOD	0
5	wounds	wound	I-NP	NNS	O	3	PMOD	0
6	showed	show	B-VP	VBD	O	0	ROOT	0
7	increased	increase	B-NP	VBN	O	8	NMOD	0
8	activity	activity	I-NP	NN	O	6	OBJ	0
9	relative	relative	B-ADVP	JJ	O	8	NMOD	0
10	to	to	B-PP	TO	O	9	AMOD	0
11	non-stimulated	non-stimulated	B-NP	JJ	O	13	NMOD	0
12	control	control	I-NP	NN	O	13	NMOD	0
13	wounds	wound	I-NP	NNS	O	10	PMOD	0
14	between	between	B-PP	IN	O	6	VMOD	0
15	7	7	B-NP	CD	O	17	AMOD	0
16	and	and	I-NP	CC	O	17	AMOD	0
17	14	14	I-NP	CD	O	18	NMOD	0
18	days	day	I-NP	NNS	O	14	PMOD	0
19	following	follow	B-PP	VBG	O	18	NMOD	0
20	injury	injury	B-NP	NN	O	19	PMOD	0
21	,	,	O	,	O	6	P	0
22	with	with	B-PP	IN	O	6	VMOD	0
23	peak	peak	B-NP	JJ	O	24	NMOD	0
24	activity	activity	I-NP	NN	O	22	PMOD	0
25	at	at	B-PP	IN	O	6	VMOD	0
26	14	14	B-NP	CD	O	27	NMOD	0
27	days	day	I-NP	NNS	O	25	PMOD	0
28	.	.	O	.	O	6	P	0

1	By	By	B-PP	IN	O	8	VMOD	0
2	21	21	B-NP	CD	O	3	NMOD	0
3	days	day	I-NP	NNS	O	1	PMOD	0
4	post-injury	post-injury	B-ADJP	JJ	O	3	NMOD	0
5	,	,	O	,	O	8	P	0
6	all	all	B-NP	DT	O	7	NMOD	0
7	activity	activity	I-NP	NN	O	8	SUB	0
8	had	have	B-VP	VBD	O	0	ROOT	0
9	returned	return	I-VP	VBN	O	8	VC	0
10	to	to	B-PP	TO	O	9	VMOD	0
11	near	near	B-PP	IN	O	10	PMOD	0
12	baseline	baseline	B-NP	NN	O	13	NMOD	0
13	level	level	I-NP	NN	O	11	PMOD	0
14	.	.	O	.	O	8	P	0

1	VEGF	VEGF	B-NP	NN	B-protein	4	NMOD	0
2	and	and	I-NP	CC	O	4	NMOD	0
3	COL-IV	COL-IV	I-NP	NN	O	4	NMOD	0
4	levels	level	I-NP	NNS	O	5	SUB	0
5	were	be	B-VP	VBD	O	0	ROOT	0
6	found	find	I-VP	VBN	O	5	VC	0
7	to	to	I-VP	TO	O	8	VMOD	0
8	be	be	I-VP	VB	O	6	VMOD	0
9	significantly	significantly	B-ADJP	RB	O	10	AMOD	0
10	higher	high	I-ADJP	JJR	O	8	PRD	0
11	for	for	B-PP	IN	O	10	AMOD	0
12	pattern	pattern	B-NP	NN	O	13	NMOD	0
13	A	A	I-NP	NN	O	11	PMOD	0
14	(	(	O	(	O	19	DEP	0
15	110	110	B-NP	CD	O	18	NMOD	0
16	mus	mus	I-NP	NN	O	18	NMOD	0
17	pulse	pulse	I-NP	NN	O	18	NMOD	0
18	width	width	I-NP	NN	O	19	DEP	0
19	)	)	O	)	O	13	NMOD	0
20	compared	compare	B-VP	VBN	O	10	AMOD	0
21	to	to	B-PP	TO	O	20	VMOD	0
22	pattern	pattern	B-NP	NN	O	23	NMOD	0
23	B	B	I-NP	NN	O	21	PMOD	0
24	(	(	O	(	O	29	DEP	0
25	5	5	B-NP	CD	O	28	NMOD	0
26	mus	mus	I-NP	NN	O	28	NMOD	0
27	pulse	pulse	I-NP	NN	O	28	NMOD	0
28	width	width	I-NP	NN	O	29	DEP	0
29	)	)	O	)	O	23	NMOD	0
30	at	at	B-PP	IN	O	20	VMOD	0
31	14	14	B-NP	CD	O	32	NMOD	0
32	days	day	I-NP	NNS	O	30	PMOD	0
33	,	,	O	,	O	6	P	0
34	implying	imply	B-VP	VBG	O	6	VMOD	0
35	that	that	B-SBAR	IN	O	34	VMOD	0
36	pattern	pattern	B-NP	NN	O	37	NMOD	0
37	A	A	I-NP	NN	O	38	SUB	0
38	may	may	B-VP	MD	O	35	SBAR	0
39	be	be	I-VP	VB	O	38	VC	0
40	more	more	B-ADJP	RBR	O	41	AMOD	0
41	effective	effective	I-ADJP	JJ	O	39	PRD	0
42	at	at	B-PP	IN	O	41	AMOD	0
43	promoting	promote	B-VP	VBG	O	42	PMOD	17	promoting
44	angiogenesis	angiogenesis	B-NP	NN	O	43	OBJ	3	angiogenesis
45	.	.	O	.	O	5	P	0

1	All	All	B-NP	DT	O	2	NMOD	0
2	wounds	wound	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	0
4	fully	fully	I-VP	RB	O	3	VMOD	0
5	re-epithelialized	re-epithelialize	I-VP	VBN	O	3	VC	0
6	by	by	B-PP	IN	O	5	VMOD	0
7	10	10	B-NP	CD	O	8	NMOD	0
8	days	day	I-NP	NNS	O	6	PMOD	0
9	post-injury	post-injury	B-ADJP	JJ	O	8	NMOD	0
10	.	.	O	.	O	3	P	0

1	Both	Both	O	CC	O	4	NMOD	0
2	COL-I	COL-I	B-NP	NN	B-protein	4	NMOD	0
3	and	and	I-NP	CC	O	4	NMOD	0
4	COL-V	COL-V	I-NP	NN	B-protein	5	SUB	0
5	showed	show	B-VP	VBD	O	0	ROOT	0
6	statistically	statistically	B-ADJP	RB	O	5	VMOD	0
7	significant	significant	I-ADJP	JJ	O	5	VMOD	0
8	(	(	O	(	O	13	DEP	0
9	P	P	B-NP	NN	O	11	SUB	0
10	less	less	B-ADJP	JJR	O	11	AMOD	0
11	than	than	B-PP	IN	O	13	DEP	0
12	0.05	0.05	B-NP	CD	O	11	AMOD	0
13	)	)	O	)	O	7	NMOD	0
14	increased	increase	B-VP	VBD	O	7	DEP	0
15	activity	activity	B-NP	NN	O	14	OBJ	17	activity
16	between	between	B-PP	IN	O	14	VMOD	0
17	day	day	B-NP	NN	O	20	NMOD	0
18	7	7	I-NP	CD	O	17	NMOD	0
19	and	and	O	CC	O	20	NMOD	0
20	day	day	B-NP	NN	O	16	PMOD	0
21	14	14	I-NP	CD	O	20	NMOD	0
22	for	for	B-PP	IN	O	20	NMOD	0
23	pattern	pattern	B-NP	NN	O	24	NMOD	0
24	A	A	I-NP	NN	O	22	PMOD	0
25	,	,	O	,	O	14	P	0
26	potentially	potentially	B-VP	RB	O	14	VMOD	0
27	indicating	indicate	I-VP	VBG	O	14	VMOD	0
28	a	a	B-NP	DT	O	30	NMOD	0
29	continued	continued	I-NP	JJ	O	30	NMOD	0
30	effect	effect	I-NP	NN	O	27	OBJ	16	effect
31	on	on	B-PP	IN	O	30	NMOD	0
32	matrix	matrix	B-NP	NN	O	33	NMOD	0
33	remodeling	remodeling	I-NP	NN	O	31	PMOD	7	remodeling
34	.	.	O	.	O	5	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	early	early	I-NP	JJ	O	3	NMOD	0
3	closure	closure	I-NP	NN	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	all	all	B-NP	DT	O	6	NMOD	0
6	wounds	wound	I-NP	NNS	O	4	PMOD	0
7	implies	imply	B-VP	VBZ	O	0	ROOT	0
8	that	that	B-SBAR	IN	O	7	VMOD	0
9	the	the	B-NP	DT	O	12	NMOD	0
10	rabbit	rabbit	I-NP	NN	O	12	NMOD	0
11	ear	ear	I-NP	NN	O	12	NMOD	0
12	model	model	I-NP	NN	O	13	SUB	0
13	may	may	B-VP	MD	O	8	SBAR	0
14	not	not	I-VP	RB	O	13	VMOD	0
15	be	be	I-VP	VB	O	13	VC	0
16	valid	valid	B-ADJP	JJ	O	15	PRD	0
17	for	for	B-PP	IN	O	16	AMOD	0
18	chronic	chronic	B-NP	JJ	O	20	NMOD	0
19	wound	wound	I-NP	JJ	O	20	NMOD	0
20	studies	study	I-NP	NNS	O	17	PMOD	0
21	.	.	O	.	O	7	P	0

